Visit Our Blog
  • About FDNA™
    • Careers at FDNA
    • Contact
  • Products
    • Face2Gene™
    • FDNA Health™
  • Blog
  • News & Publications
  • Blog

Categories
  • All
  • ACMG
  • Case Study
  • Diagnostic odyssey
  • Events/Conferences
  • Face2Gene
  • Geneticist profile
  • Genomics
  • Phenotyping
  • Rare Diseases
  • Scientific Abstracts
  • Talks
  • Technology
  • Uncategorized
  • Videos

Drew’s Journey with Noonan Syndrome

March 31, 2017

By FDNA Team

Face2Gene,Genomics,Phenotyping,Rare Diseases

Photo of Drew

This month in the Year of Discovery, FDNA spotlights syndromes categorized as RASopathies. Every case uploaded in March will be matched with a $1 donation sponsored by Blueprint Genetics and benefiting the Noonan Syndrome Foundation.* Every time a patient’s case is analyzed by Face2Gene, the de-identified information will train the system to recognize new associations between phenotypes, facial characteristics and genes. This information will improve our understanding of rare diseases and directly impact the lives of patients and families for years to come.

Noonan Syndrome is a genetic disease that can cause many symptoms, including short stature, abnormal bleeding and, for most patients, heart defects resulting in congenital heart disease.

Drew was one such patient treated at Lurie Children’s Hospital of Chicago. Drew’s mother, Katie, now serving on the board of the Noonan Syndrome Foundation, shared Drew’s deeply touching story.

Drew was diagnosed with Noonan Syndrome prenatally at 19 weeks. Drew’s parents began studying and preparing for an extraordinary child. They specifically chose Lurie Children’s Hospital to see them through any potential complications early in Drew’s life.

Drew was born in 2012 without any complications, bypassing the Neonatal Intensive Care Unit (NICU), much to the surprise of the team standing by. He was diagnosed with mild pulmonary stenosis and an atrial septal defect but otherwise, healthy and able to go home with his parents after just two days at Lurie’s. Still, Drew’s parents had prepared with a team of doctors and everyone was watchful for issues associated with Noonan Syndrome. They took him to a scheduled checkup at Lurie’s when he was 2 months old where a chest x-ray confirmed that Noonan Syndrome complications had developed.

“We were at the outpatient center at Northwest Community for Lurie’s and I will never forget this day. Drew was in for a routine follow-up ECG and the technician found what appeared to be fluid that was surrounding his lungs,” said Katie.

Drew was admitted and it was found that he had bilateral plural effusions and a chest tube was necessary to drain the fluid. Drew was on the pulmonary floor for about 10 days and the doctors were quite puzzled as to why he was still draining so much fluid.

After 10 days in the hospital with Drew, Katie and her husband went home to regroup and spend time with their older son. On their way home, she received a call saying that Drew should be moved to the Pediatric Intensive Care Unit (PICU) as a precaution. In that terrifying moment, she trusted the team she had chosen at Lurie’s and was ready to take any precautions needed for her son. The team at Lurie’s was right. PICU was the best place for Drew later that night when further complications developed.

“It was 1AM when we got a dreaded phone call that Drew was going into respiratory failure and it required the doctors in the PICU to place him on a respirator,” said Katie. “This was probably the most pivotal moment in his health to date. My husband and I made it back down to the hospital to find that Drew was almost unrecognizable as he was retaining an incredible amount of fluid.”

Over that next day, his health deteriorated and all his organs were failing. Katie and her husband felt helpless. When they left to rest at the Ronald McDonald House, another phone call came through. Drew’s only chance of survival now was a machine called ECMO.

“I had never heard of it, however, no picture could ever brace you for what you are about to see when your child is hooked up to this machine,” said Katie. She knew in that moment that she was desperate for a miracle. ECMO gave Drew’s organs a break and allowed him to fight. He developed a brain bleed 5 days in and was taken off of ECMO on the 7th day. He was 4 months old.

Drew endured many challenges in the weeks ahead. There were more terrifying moments and setbacks but steadily his health did improve thanks to the care of the team at Lurie’s and his parents. Drew was a patient at Lurie Children’s for 3 full months, 93 days to be exact. Today Drew is a thriving 4-year-old boy. He has a team of doctors, many from his early team at Lurie’s, that continues to care for him.

“The only constant throughout this whole journey was the team of medical professionals,” said Katie. “Between the doctors and the nurses, it was beyond comforting that everyone was fighting for Drew to be a miracle.”

For rare and genetic disorders, the journey can be long and it can be difficult to hold onto hope for a diagnosis, treatment or even survival. Drew was diagnosed prenatally at 19 weeks but an early diagnosis like his isn’t common. It takes on average 7 years and 7 doctors to reach an accurate diagnosis. Even with a diagnosis, the journey doesn’t end there. Drew’s story is a testament to the need for advancements in research and treatment for rare diseases like Noonan Syndrome. With new technology and a united community, we can work together to provide hope for patients and families like this one.

“There are so many kids out there that need to know what HOPE means and to NEVER EVER GIVE UP!” said Katie.

 

Noonan Syndrome was first described by Noonan and Ehmke in 1963 and affects an estimated 1 in 1,000 to 2,500 people. The facial phenotype includes features such as a deep philtrum, wide-set eyes and low-set ears.

Noonan Syndrome and other RASopathies are recognized by Face2Gene because numerous patient photos and case uploads have taught the artificial intelligence system to recognize Noonan related facial features and other associated phenotypes.

Healthcare Professionals: Do you have cases to upload that can help Face2Gene recognize RASopathies and accelerate advancements? Contact us for help getting started.

Patients and Families: Ask your doctor to add your or your child’s case to Face2Gene. The personal information will only be accessible to your doctor but the de-identified data may help others who are battling a rare disease. Click here for more information.

 

*All donations are provided directly by the participating sponsor in such month and at its sole responsibility. Amounts may be capped to a maximum in each month, at the participating sponsor’s sole discretion.

More entries about Face2Gene

Face2Gene
 

Quer dominar o Face2Gene? Veja os tutoriais disponíveis

Face2Gene é um conjunto de tecnologias que visa ajudar os médicos a acelerar o tempo de diagnóstico de condições genéticas Read more

Face2Gene
 

All the tutorials available to help you master Face2Gene

Face2Gene is a suit of technologies that aims to help clinicians to fasten the time of diagnosis of rare and Read more

Face2Gene
 

O Pediatrician View em português, por Dr Pablo J. Videla Vilá

O Dr. Pablo Videla fala sobre o novo Pediatrician View, uma tecnologia recentemente desenvolvida pela FDNA Inc., e disponível no Read more

Face2Gene
 

The importance of assigning a diagnosis to your cases

Face2Gene is an AI-driven tool that uses a set of proprietary algorithms engineered to learn from diagnosed patient photos to Read more

Face2Gene
 

Pediatrician View en español, por el doctor Pablo Videla

El Dr. Pablo Videla habla sobre la Pediatrician View, la nueva tecnología desarrollada por FDNA. Este nuevo algoritmo permite a Read more

Face2Gene
 

Spanish press highlights Face2Gene AI Technology that helps detect rare syndrome using a patient’s photo

Thanks to Face2Gene, doctors have an ally to make the diagnosis By ALEXIA COLUMBA JEREZ Publish by ABC News (Spain). Read more

Face2Gene
 

Use Face2Gene as a Team

Collaborate on Shared Cases with your colleagues leveraging cumulative knowledge Using Face2Gene as a TEAM allows you to securely share Read more

Face2Gene
 

Are you sequencing upfront?

With this new update, healthcare providers can use Face2Gene to search for genes within the phenotypic results. A form of Read more

Face2Gene
 

What’s new in Face2Gene?

Check out the new and improved AI capabilities designed to help you diagnose patients earlier (October 2022 updates): Instantly extract Read more

Rare Diseases
 

KBG Foundation partnered with FDNA to help improve earlier diagnose of KBG Syndrome

Manchester, Md. – KBG Foundation, a U.S.-based nonprofit organisation working to improve the lives of people with KBG Syndrome, is Read more

Face2Gene
 

Patient Matching

Face2Gene Patient Matching aims to use de-identified facial patterns and other clinical data in your case to find phenotypic similarities Read more

Face2Gene
 

Extracting Features From Clinical Notes

DID YOU KNOW: By adding clinical features to your cases in Face2Gene, you increase the possible syndrome matches to 7,000+. NEW: Include features Read more

Face2Gene
 

2018 Year in Review

It was an exciting 2018 for FDNA, as we continued on our path to bring AI-based phenotyping technologies to clinicians, Read more

Events/Conferences
 

What to Do and See at ASHG 2018

San Diego, CA – The FDNA team is excited to be back at the American Society of Human Genetics (ASHG) Read more

Face2GeneTalksVideos
 

The Genomics Collaborative: How to Design the Future of Health—Together

  ThinkGenetic recently hosted a panel discussion among researchers involved in the Genomics Collaborative, an FDNA initiative connecting researchers, clinicians, Read more

Events/Conferences
 

FDNA and Face2Gene Featured at ESHG

  A flock of researchers from around the globe shared their findings in dysmorphology and molecular genetics at this year’s Read more

Events/Conferences
 

What to Do and See at ESHG

The European Society of Human Genetics (ESHG) 42nd Annual  Meeting 2018 MiCo – Milano Congressi · Milan, Italy · June Read more

ACMG
 

Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this link> Read more

ACMG
 

Dr. John Carey: Delineating Genetic Syndromes and Next-Generation Phenotyping

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more

ACMG
 

Dr. Karen Gripp: Face2Gene RESEARCH for Deep Phenotyping of Novel Syndromes

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more

  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Careers at FDNA™

Signup for News


* These fields are required.

© 2011-2023 FDNA INC. www.FDNA.com. All rights reserved.

Face2Gene is a search and reference tool provided for informational purposes and not intended to replace the clinician’s judgment or experience, nor should it be used to diagnose or treat medical conditions.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. Check our Cookie Policy.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT